Please login to the form below
KOL Strategy
This page shows the latest KOL Strategy news and features for those working in and with pharma, biotech and healthcare.
New accounts: September
Aranesp KOL strategy. Oncology. central. Amgen European HQ. Mimpara meetings. Nephrology. ... central. Amgen European HQ. Neulasta KOL strategy. Oncology. central. Baxter Healthcare UK.
Latest news
-
New accounts: October
Amgen European HQ. Aranesp KOL strategy. Oncology. central. Amgen European HQ. ... Mimpara meetings. Nephrology. central. Amgen European HQ. Neulasta KOL strategy. Oncology.
-
New accounts: November
Allergan. Botox. Neurology. Jango Communications. Amgen European HQ. Aranesp KOL strategy. ... Neulasta KOL strategy. Oncology. central. GlaxoSmithKline. Cervarix. Cervical cancer (consumer healthcare).
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
Sandra has extensive experience working in physician, patient, and brand strategy; product marketing; digital; and KOL engagement.
-
emotive. expands Medical Writing and Client Services teams
She brings a breadth of knowledge in pre-launch strategy and tactical implementation, KOL development, patient engagement, disease awareness and CME programmes, working with both marketing and medical clients.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director - Med Comms Agency
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- GSK launches late-stage testing of RSV vaccine candidate in older adults
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- Sinovac’s COVID-19 vaccine appears safe in older adults
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- FDA schedules meeting on 26 February to review J&J’s one-dose COVID-19 vaccine
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- Merck to acquire Pandion Therapeutics for $1.85bn
- bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
